Diagnosing Alzheimer's disease early presents significant challenges primarily because current medical interventions are limited. While detecting the disease early is crucial, effective therapies are not yet widely available. Recent advancements in clinical trials have introduced drugs aimed at lowering brain amyloid levels, showing promising results in removing amyloid through intravenous infusions. These drugs have demonstrated efficacy in slowing disease progression in symptomatic individuals by significantly reducing amyloid levels, which is believed to be central to Alzheimer's pathology. Although there is hope that these treatments may eventually be applicable to asymptomatic individuals, definitive answers regarding their effectiveness in early intervention remain undetermined.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode